An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo
††Electronic supplementary information (ESI) available: Experimental materials and methods, characterization details of all compounds, X-ray crystal structures. CCDC 1499561 and 1499562. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6sc03862jClick here for additional data file.Click here for additional data file. Here, ALB is linked to neoplasm.